(Q48738509)

15 February 2018

title

Dysregulation of Ca2+ homeostasis in Alzheimer's disease: role in acetylcholinesterase production and AMPA receptor internalization. (English)

1 reference

15 February 2018

0 references

David H Small

1

1 reference

15 February 2018

publication date

1 February 2012

1 reference

15 February 2018

Neurodegenerative Diseases

published in

1 reference

15 February 2018

volume

10

1 reference

15 February 2018

issue

1-4

1 reference

15 February 2018

page(s)

76-79

1 reference

15 February 2018

Alzheimer's disease and Abeta toxicity: from top to bottom

cites work

1 reference

Cholesterol is necessary both for the toxic effect of Abeta peptides on vascular smooth muscle cells and for Abeta binding to vascular smooth muscle cell membranes

21 January 2018

1 reference

Regulation of NMDA receptor trafficking by amyloid-beta

21 January 2018

1 reference

Does the p75 neurotrophin receptor mediate Abeta-induced toxicity in Alzheimer's disease?

21 January 2018

1 reference

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

21 January 2018

1 reference

Aβ(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β.

21 January 2018

1 reference

Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression.

21 January 2018

1 reference

Calcium dysregulation in Alzheimer's disease: from mechanisms to therapeutic opportunities

21 January 2018

1 reference

Long-term synaptic plasticity in hippocampal interneurons

21 January 2018

1 reference

Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders

21 January 2018

1 reference

Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines

21 January 2018

1 reference

Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum

21 January 2018

1 reference

Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases

21 January 2018

1 reference

Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks

21 January 2018

1 reference

Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease.

21 January 2018

1 reference

Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition.

21 January 2018

1 reference

Changes in molecular isoform distribution of acetylcholinesterase in rat cortex and cerebrospinal fluid after intracerebroventricular administration of amyloid beta-peptide.

21 January 2018

1 reference

Routes, destinations and delays: recent advances in AMPA receptor trafficking

21 January 2018

1 reference

Differential preservation of AMPA receptor subunits in the hippocampi of Alzheimer's disease patients according to Braak stage

21 January 2018

1 reference

Glutamate receptor dysregulation in the hippocampus of transgenic mice carrying mutated human amyloid precursor protein

21 January 2018

1 reference

AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss

21 January 2018

1 reference

Network dysfunction in Alzheimer's disease: does synaptic scaling drive disease progression?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000333126

1 reference

15 February 2018

PubMed ID

22301681

1 reference

15 February 2018